Physician profile
Sean Clare
NPI 1366507113
$1,365.36
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114 · 2020: $192 · 2021: $502 · 2022: $225 · 2023: $229 · 2024: $103.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $332.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $331.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $385.68 | 2020-2022 | |
| Hologic Sales and Service, LLC | $251.39 | 2020-2024 | Aptima, Novasure |
| Medtronic, INC. | $152.88 | 2023 | Interstim |
| Therapeuticsmd, INC. | $81.24 | 2019-2022 | |
| Pfizer INC. | $75.53 | 2019-2021 | |
| Mayne Pharma Commercial LLC | $66.74 | 2022-2023 | |
| Organon LLC | $63.52 | 2021-2022 | |
| Allergan, INC. | $41.28 | 2019-2020 | |
| Innovation Technologies INC | $35.52 | 2024 | Irrisept |
| Aspira Women'S Health INC | $30.59 | 2019-2022 | |
| Roche Diagnostics Corporation | $22.83 | 2019 | |
| Amag Pharmaceuticals, INC. | $22.61 | 2019 | |
| Mylan Pharmaceuticals INC. | $22.28 | 2021 | |
| Astellas Pharma US INC | $20.26 | 2020 | |
| Olympus America INC. | $19.82 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $16.80 | 2021 | |
| Exact Sciences Corporation | $16.02 | 2023 | Cologuard Collection Kit |
| Ascend Therapeutics US, LLC | $15.71 | 2021 | |
| Merck Sharp & Dohme LLC | $13.49 | 2021 | |
| Davol INC. | $11.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Clare listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.